| Entry | Database: PDB / ID: 6p3d |
|---|
| Title | The co-crystal structure of BRAF(V600E) with ponatinib |
|---|
Components | Serine/threonine-protein kinase B-raf |
|---|
Keywords | TRANSFERASE/TRANSFERASE INHIBITOR / kinase / inhibitor / cancer / melanoma / TRANSFERASE-TRANSFERASE INHIBITOR complex / ONCOPROTEIN |
|---|
| Function / homology | Function and homology information
Signalling to p38 via RIT and RIN / ARMS-mediated activation / SHOC2 M1731 mutant abolishes MRAS complex function / Gain-of-function MRAS complexes activate RAF signaling / positive regulation of D-glucose transmembrane transport / establishment of protein localization to membrane / Negative feedback regulation of MAPK pathway / Frs2-mediated activation / MAP kinase kinase activity / positive regulation of peptidyl-serine phosphorylation ...Signalling to p38 via RIT and RIN / ARMS-mediated activation / SHOC2 M1731 mutant abolishes MRAS complex function / Gain-of-function MRAS complexes activate RAF signaling / positive regulation of D-glucose transmembrane transport / establishment of protein localization to membrane / Negative feedback regulation of MAPK pathway / Frs2-mediated activation / MAP kinase kinase activity / positive regulation of peptidyl-serine phosphorylation / MAP kinase kinase kinase activity / postsynaptic modulation of chemical synaptic transmission / animal organ morphogenesis / cellular response to calcium ion / RAF activation / Signaling by high-kinase activity BRAF mutants / Spry regulation of FGF signaling / MAP2K and MAPK activation / epidermal growth factor receptor signaling pathway / Signaling by RAF1 mutants / Signaling by moderate kinase activity BRAF mutants / Paradoxical activation of RAF signaling by kinase inactive BRAF / Signaling downstream of RAS mutants / MAPK cascade / Negative regulation of MAPK pathway / Signaling by BRAF and RAF1 fusions / cell body / scaffold protein binding / positive regulation of ERK1 and ERK2 cascade / protein kinase activity / protein phosphorylation / non-specific serine/threonine protein kinase / postsynapse / neuron projection / protein serine kinase activity / protein serine/threonine kinase activity / positive regulation of gene expression / calcium ion binding / negative regulation of apoptotic process / glutamatergic synapse / mitochondrion / zinc ion binding / ATP binding / identical protein binding / nucleus / plasma membrane / cytosol / cytoplasmSimilarity search - Function Raf-like Ras-binding domain / Raf-like Ras-binding / Ras-binding domain (RBD) profile. / Raf-like Ras-binding domain / Diacylglycerol/phorbol-ester binding / Phorbol esters/diacylglycerol binding domain (C1 domain) / : / Zinc finger phorbol-ester/DAG-type signature. / Zinc finger phorbol-ester/DAG-type profile. / Protein kinase C conserved region 1 (C1) domains (Cysteine-rich domains) ...Raf-like Ras-binding domain / Raf-like Ras-binding / Ras-binding domain (RBD) profile. / Raf-like Ras-binding domain / Diacylglycerol/phorbol-ester binding / Phorbol esters/diacylglycerol binding domain (C1 domain) / : / Zinc finger phorbol-ester/DAG-type signature. / Zinc finger phorbol-ester/DAG-type profile. / Protein kinase C conserved region 1 (C1) domains (Cysteine-rich domains) / Protein kinase C-like, phorbol ester/diacylglycerol-binding domain / C1-like domain superfamily / Protein tyrosine and serine/threonine kinase / Serine-threonine/tyrosine-protein kinase, catalytic domain / Ubiquitin-like domain superfamily / Transferase(Phosphotransferase) domain 1 / Transferase(Phosphotransferase); domain 1 / Serine/threonine-protein kinase, active site / Serine/Threonine protein kinases active-site signature. / Serine/Threonine protein kinases, catalytic domain / Protein kinase, ATP binding site / Protein kinases ATP-binding region signature. / Protein kinase domain profile. / Protein kinase domain / Protein kinase-like domain superfamily / Orthogonal Bundle / Mainly AlphaSimilarity search - Domain/homology |
|---|
| Biological species | Homo sapiens (human) |
|---|
| Method | X-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 2.11 Å |
|---|
Authors | Agianian, B. / Gavathiotis, E. |
|---|
| Funding support | United States, 1items | Organization | Grant number | Country |
|---|
| National Institutes of Health/National Cancer Institute (NIH/NCI) | 1R01CA178394 | United States |
|
|---|
Citation | Journal: Nat Commun / Year: 2020Title: Inhibitors of BRAF dimers using an allosteric site. Authors: Cotto-Rios, X.M. / Agianian, B. / Gitego, N. / Zacharioudakis, E. / Giricz, O. / Wu, Y. / Zou, Y. / Verma, A. / Poulikakos, P.I. / Gavathiotis, E.#1: Journal: Cancer Cell / Year: 2016Title: An Integrated Model of RAF Inhibitor Action Predicts Inhibitor Activity against Oncogenic BRAF Signaling. Authors: Karoulia, Z. / Wu, Y. / Ahmed, T.A. / Xin, Q. / Bollard, J. / Krepler, C. / Wu, X. / Zhang, C. / Bollag, G. / Herlyn, M. / Fagin, J.A. / Lujambio, A. / Gavathiotis, E. / Poulikakos, P.I. |
|---|
| History | | Deposition | May 23, 2019 | Deposition site: RCSB / Processing site: RCSB |
|---|
| Revision 1.0 | Sep 23, 2020 | Provider: repository / Type: Initial release |
|---|
| Revision 1.1 | Mar 13, 2024 | Group: Data collection / Database references / Category: chem_comp_atom / chem_comp_bond / database_2 Item: _database_2.pdbx_DOI / _database_2.pdbx_database_accession |
|---|
|
|---|